SavedAdd your journal

Journals / Eurasian Journal of Medicine / 2014 / Cilt: 46 - Sayı: 1

Kan transfüzyonun ekonomik etkisi: Maliyet ve yararı dengelemek

Economic impact of blood transfusions: Balancing cost and benefits

Gokhan Sami KILIC
Tufan OGE
Cemil Hakan KILIC
Pages
47–49
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, we evaluate the financial burden tothe health care system.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Blood transfusions may be lifesaving, but they inherit their own risks.
📊
Key Findings & Data:In this review, we aimed to discuss thetransfusion strategies and share our transfusion protocol as well as thesteps for hospitals to build-up a blood management program while allthese factors weight in.
💡
Conclusion & Impact:Moreover, we evaluate the financial burden tothe health care system.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Blood transfusions may be lifesaving, but they inherit their own risks. Riskof transfusion to benefit is a delicate balance. In addition, blood prod-uct transfusions purchases are one of the largest line items among thehospital and laboratory charges. In this review, we aimed to discuss thetransfusion strategies and share our transfusion protocol as well as thesteps for hospitals to build-up a blood management program while allthese factors weight in. Moreover, we evaluate the financial burden tothe health care system.

Özet

Kan transfüzyonu hayat kurtarıcı olabilir bunun yanında transfüzyonun kendi risklerini de taşır. Transfüzyonun yararı ve riski arasında hassas bir denge vardır. Buna ilave olarak kan ürünlerinin transfüzyonu en büyük hastane ve laboratuar harcamalarından birini oluşturur.Bu derlemede transfüzyon stratejilerini ve hastanemizde kullandığımız transfüzyon politikası ile hastanelerin kan yönetim programlarınıoluşturmak için gereken basamakları tartışmayı amaçladık. Buna ilave olarak sağlık kurumlarına olan finansal yükü değerlendirdik.

🔖

Cite This Article

KILIC, G. S., OGE, T., KILIC, C. H. (2022). Kan transfüzyonun ekonomik etkisi: Maliyet ve yararı dengelemek. Eurasian Journal of Medicine, Cilt: 46 - Sayı: 1, 47–49. https://ajindex.com/articles/509142

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hare GM, Freedman J, David Mazer C. Review article: risks of anemia and related management strategies: can perioperative blood management improve patient safety? Can J Anaesth 2013
  2. [CrossRef] 2. Shander A, Javidroozi M, Ozawa S, et al. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011
  3. 107 Suppl 1: i41-59. [CrossRef] 3. Olgun H, Buyukavci M, Sepetcigil O, et al. Comparison of safety and effectiveness of two different transfusion rates in children with severe anemia. J Pediatr Hematol Oncol 2009
  4. [CrossRef] 4. Borekci B, Ingec M, Kumtepe Y, et al. Difficulty of the surgical management of a case with placenta percreta invading towards parametrium. J Obstet Gynaecol Res 2008
  5. [CrossRef] 5. Patel MS, Carson JL. Anemia in the preoperative patient. Anesthesiol Clin 2009
  6. [CrossRef] 6. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999
  7. [CrossRef] 7. Carless PA, Henry DA, Carson JL, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2010: CD002042. 8. Nichol AD, Westbrook A, Bellomo R, et al. Is it too early to recom- mend a restrictive transfusion strategy in critically ill patients with ischemic heart disease? Crit Care Med 2008
  8. [CrossRef] 9. Nichol AD. Restrictive red blood cell transfusion strategies in critical care: does one size really fit all? Crit Care Resusc 2008
  9. Cetinkaya K, Kumtepe Y, Ingec M. Minimally invasive approach to cases of lost intra-uterine device: a 7-year experience. Eur J Obstet Gynecol Reprod Biol 2011
  10. [CrossRef] 11. Walsh TM, Borahay MA, Fox KA, et al. Robotic-assisted, ultra- sound-guided abdominal cerclage during pregnancy: overcom- ing minimally invasive surgery limitations? J Minim Invasive Gynecol 2013
  11. [CrossRef] 12. Kilic GS, Moore G, Elbatanony A, et al. Comparison of periop- erative outcomes of total laparoscopic and robotically assisted hysterectomy for Benign Pathology during introduction of a Robotic Program. Obstet Gynecol Int 2011
  12. 683703. [CrossRef] 13. Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet 2013
  13. [CrossRef] 14. Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2007 A